Academics
follow us
  • Linkedin
  • Twitter
  • Facebook
  • Youtube
  • Instagram
Feedback
Patent Number:- US20210038612

Mucoadhesive Drug Delivery System for Ocular Administration of Fluoroquinolone Antibiotics

  • Sector: Pharmaceutical Technology,
  • IPC: A61K, A61P,
 

Need

There's a need for improved compositions and treatment methods using antibiotics that are highly effective against ophthalmic pathogens and less prone to resistance.

Solution

The disclosure presents mucoadhesive pharmaceutical compositions containing fluoroquinolone antibiotics, chitosan, polyvinyl alcohol, and polyvinylpyrrolidone.

Innovation

Developing a pharmaceutical composition with a combination of fluoroquinolone antibiotic, chitosan, polyvinyl alcohol, and polyvinylpyrrolidone for improved treatment of ophthalmic infections.

Market Analysis

Market: Eye Care, Mucoadhesive Drug Formulations

CAGR: Moderate growth, driven by innovations in targeted therapies

Potential Indian Clients:Pharmaceutical companies, eye care clinics

Why Invest?


Mucoadhesive

Mucoadhesive

Prodrugs

Hydrogel

At a Glance


Current TRL: NA

Funded by: NA

IPC: A61K, A61P

Domain: Pharmaceutical, Ocular Drug Delivery

For more information, reach out to Mr. Rajneesh Kumar, Head of the Technology Transfer Office, at tto@bits-pilani.ac.in and 01596-255515.